Consumer group petitions FDA to ban obesity drug Meridia

12/3/2009 | Google

Consumer group Public Citizen urged the FDA to pull Abbott Laboratories' Meridia from the market in light of a study linking the obesity drug to a heightened risk of heart attack, stroke and death. Abbott clarified that Meridia is not promoted for patients with a history of cardiovascular disease and "is not recommended or approved for use in more than 90% of the patients" in the study cited by Public Citizen.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN